RAFAEL HOLDINGS, INC. Business Combination, Acquisition Related Costs
RAFAEL HOLDINGS, INC. (RFL) reported Business Combination, Acquisition Related Costs of $1.10 million for the 9-month period ending 2026-04-30, per its 10-Q filed 2026-06-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:BusinessCombinationAcquisitionRelatedCosts · last filed 2026-06-11
- RAFAEL HOLDINGS, INC. business combination, acquisition related costs for the quarter ending 2025-07-31 was $0.00.
- RAFAEL HOLDINGS, INC. business combination, acquisition related costs for the quarter ending 2025-04-30 was $200.00K.
- RAFAEL HOLDINGS, INC. business combination, acquisition related costs for the quarter ending 2025-01-31 was $100.00K.
- RAFAEL HOLDINGS, INC. business combination, acquisition related costs for the quarter ending 2024-10-31 was $100.00K.
- RAFAEL HOLDINGS, INC. business combination, acquisition related costs for fiscal 2025 was $1.00M, a 900.00% increase from fiscal 2024.
- RAFAEL HOLDINGS, INC. business combination, acquisition related costs for fiscal 2024 was $100.00K.
| Period end | Business Combination, Acquisition Related Costs 3 month | Business Combination, Acquisition Related Costs 6 month | Business Combination, Acquisition Related Costs 9 month | Business Combination, Acquisition Related Costs 12 month |
|---|---|---|---|---|
| 2026-04-30 | $1.10M 10-Q · filed 2026-06-11 | |||
| 2025-07-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | $200.00K derived: sum of 2 quarters · filed 2026-06-11 | $300.00K derived: sum of 3 quarters · filed 2026-06-11 | $1.00M 10-K · filed 2025-10-29 |
| 2025-04-30 | $200.00K 10-Q · filed 2026-06-11 | $300.00K derived: sum of 2 quarters · filed 2026-06-11 | $1.00M 10-Q · filed 2026-06-11 | |
| 2025-01-31 | $100.00K 10-Q · filed 2026-03-16 | $200.00K 10-Q · filed 2026-03-16 | ||
| 2024-10-31 | $100.00K 10-Q · filed 2025-12-12 | |||
| 2024-07-31 | $100.00K 10-K · filed 2025-10-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |